A.I.dvisor tells us that XBIO and ALZN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XBIO and ALZN's prices will move in lockstep.
| Ticker / NAME | Correlation To XBIO | 1D Price Change % | ||
|---|---|---|---|---|
| XBIO | 100% | -5.35% | ||
| ALZN - XBIO | 24% Poorly correlated | +2.13% | ||
| ABUS - XBIO | 24% Poorly correlated | +3.10% | ||
| GOSS - XBIO | 23% Poorly correlated | -1.20% | ||
| UBX - XBIO | 23% Poorly correlated | -4.91% | ||
| SNDX - XBIO | 23% Poorly correlated | -0.05% | ||
More | ||||
| Ticker / NAME | Correlation To XBIO | 1D Price Change % |
|---|---|---|
| XBIO | 100% | -5.35% |
| XBIO (2 stocks) | 80% Closely correlated | -3.07% |
| drugs (265 stocks) | 17% Poorly correlated | +5.37% |
| biotechnology (248 stocks) | 17% Poorly correlated | +5.56% |
| cancer (87 stocks) | 17% Poorly correlated | +0.89% |
| challenging disorders (8 stocks) | 15% Poorly correlated | -2.89% |
More | ||